2025年财务展望
公司发布了2025年的展望，摘要如下：
- 2025年的收入将在108.5亿美元至111.5亿美元之间
- 2025年的调整后EBITDA将在5.60亿美元至5.90亿美元之间
- 2025年的调整后每股收益将在1.60美元至1.85美元之间
公司的2025年展望不包括之前宣布的Rotech收购、与产品和医疗服务部门有关的任何潜在交易或股票回购活动的影响，并包含了对当前经济状况影响的预期。
支持公司2025年财务指导的关键假设包括：
- 毛利率在20.75%至21.25%之间
- 利息支出在1.38亿美元至1.42亿美元之间
- 调整后的有效税率在29.0%至30.0%之间
- 稀释后的加权平均股份约为8000万股
- 资本支出（毛额）在2.50亿美元至2.70亿美元之间
- 商品价格稳定
- 截至2024年12月31日的外汇汇率
以上内容来自Benzinga Earnings专栏，原文如下：
2025 Financial Outlook
The Company issued its outlook for 2025; summarized below:
- Revenue for 2025 to be in a range of $10.85 billion to $11.15 billion
- Adjusted EBITDA for 2025 to be in a range of $560 million to $590 million
- Adjusted EPS for 2025 to be in a range of $1.60 to $1.85
The Company's outlook for 2025 excludes any impact of the previously announced Rotech acquisition, any potential transaction involving the Products & Healthcare Services segment, or share repurchase activity, and contains assumptions, including current expectations regarding the impact of general economic conditions.
Key assumptions supporting the Company's 2025 financial guidance include:
- Gross margin of 20.75% to 21.25%
- Interest expense of $138 million to $142 million
- Adjusted effective tax rate of 29.0% to 30.0%
- Diluted weighted average shares of ~80 million
- Capital expenditures, gross, of $250 million to $270 million
- Stable commodity prices
- FX rates as of 12/31/2024